Clinical trial
OrthoPulse 2.0 and 2.1 Product Evaluation and Assessing Clinical Effectiveness: A Feasibility Study
NCT03683017 is registered in ClinicalTrials.gov with Biolux Research Holdings, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OrthoPulse 2.0 and 2.1 Product Evaluation and Assessing Clinical Effectiveness: A Feasibility Study
- Lead sponsor
- Biolux Research Holdings, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 22, 2017
- Completion date
- June 30, 2020
- Enrollment
- 35 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.